Dataset: HER2-enriched tumor initiating cell (HTIC) genomic predictor of response following neoadjuvant trastuzumab-based chemotherapy in HER2+ breast cancer
We identified a 17-gene Her2-enriched tumor initiating cell (HTIC) signature in MMTV-Her2/Neu mouse mammary TICs. Here, we show that...
We identified a 17-gene Her2-enriched tumor initiating cell (HTIC) signature in MMTV-Her2/Neu mouse mammary TICs. Here, we show that patients with HTICS+ HER2+:ERα− tumors are more likely to achieve a pathologic complete response to trastuzumab-based neoadjuvant chemotherapy compared with HER2+:ER+ tumors. Neoadjuvant study of 50 HER2-positive breast cancer cases treated with trastuzumab-based chemotherapy pre-operatively. Pre-treatment FNA from primary tumors were obtained and RNA extracted and hybridized to Affymetrix microarrays according to manufacturer protocol. Pathologic response was assessed at the end of neoadjuvant treatment.
- Species:
- human
- Samples:
- 50
- Source:
- E-GEOD-37946
- Updated:
- Dec.12, 2014
- Registered:
- Jun.18, 2014
Sample | PR | AGE | STAGE | RESPONSE | ER |
---|---|---|---|---|---|
GSM930574 | NEG | 49 | IV | RD | NEG |
GSM930573 | POS | 62 | IIIC | RD | POS |
GSM930572 | POS | 24 | IIIC | RD | POS |
GSM93057 | NEG | 54 | IIIC | RD | NEG |
GSM930570 | POS | 72 | IIB | RD | POS |
GSM930569 | NEG | 55 | IIIC | RD | NEG |
GSM930568 | NEG | 61 | IIIC | RD | NEG |
GSM930567 | POS | 48 | IIIA | RD | POS |
GSM930566 | NEG | 39 | IIIC | RD | NEG |
GSM930565 | NEG | 50 | IIIA | RD | POS |
GSM930564 | NEG | 44 | IIA | RD | NEG |
GSM930563 | NEG | 51 | IIB | RD | NEG |
GSM930562 | NEG | 61 | IIB | RD | POS |
GSM93056 | NEG | 30 | IIIB | RD | NEG |
GSM930560 | NEG | 52 | IIIA | RD | NEG |
GSM930559 | NEG | 69 | IIA | RD | NEG |
GSM930558 | NEG | 56 | IIIC | RD | POS |
GSM930557 | NEG | 73 | IIA | RD | NEG |
GSM930556 | POS | 47 | IIIC | RD | POS |
GSM930555 | NEG | 41 | IIIC | RD | NEG |
GSM930554 | POS | 49 | IIA | RD | POS |
GSM930553 | POS | 28 | IIIB | RD | POS |
GSM930552 | NEG | 57 | IIA | RD | NEG |
GSM93055 | NEG | 46 | IIIC | PCR | NEG |
GSM930550 | POS | 30 | not specified | PCR | POS |
GSM930549 | NEG | 65 | IIB | PCR | NEG |
GSM930548 | POS | 52 | IIIB | PCR | POS |
GSM930547 | NEG | 56 | IIB | PCR | NEG |
GSM93055 | NEG | 46 | IIIC | PCR | NEG |
GSM930545 | POS | 56 | IIIA | PCR | POS |
GSM930544 | NEG | 53 | IIB | PCR | NEG |
GSM930543 | NEG | 62 | IIIC | PCR | NEG |
GSM930542 | NEG | 55 | IIA | PCR | NEG |
GSM93054 | NEG | 51 | IIIB | PCR | NEG |
GSM930540 | POS | 53 | IIIA | PCR | POS |
GSM930539 | NEG | 41 | IIIC | PCR | NEG |
GSM930538 | NEG | 50 | IIIA | PCR | POS |
GSM930537 | NEG | 63 | IIA | PCR | POS |
GSM930536 | NEG | 38 | I | PCR | POS |
GSM930535 | NEG | 43 | IIIA | PCR | NEG |
GSM930534 | NEG | 51 | IIIC | PCR | NEG |
GSM930533 | NEG | 45 | IIIC | PCR | NEG |
GSM930532 | POS | 56 | IIIA | PCR | NEG |
GSM93053 | NEG | 47 | IIA | PCR | NEG |
GSM930530 | NEG | 36 | I | PCR | NEG |
GSM930529 | POS | 38 | IIA | PCR | POS |
GSM930528 | NEG | 30 | IIIA | PCR | NEG |
GSM930527 | NEG | 52 | IIIB | PCR | NEG |
GSM930526 | NEG | 34 | IIA | PCR | NEG |
GSM930525 | NEG | 50 | IIA | PCR | NEG |